Solazyme reports sharp jump in revenues, investments in scale-up, for Q2
In California, Solazyme joined the wave of companies reporting Q2 results, announcing that revenues were up 68 percent, while losses jumped from $6.8 million to $17.0 million as the company used proceeds from its IPO to begin investment in scale-up. With its heavy load of cash, the company is acquiring additional production capacity and shifting […]











